skeletal metastases

FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients
Yahoo/PR NewsWire
Sat, 07/17/10 - 09:52 am
Amgen
denosumab
skeletal metastases